Search research articles
Contact Us
Filters
Showing results (51-60 of 79) with videos related to
Page
of 8
Sort By:
European Urology Open Science
|
May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
Dominik Menges, Michela C Piatti, Aurelius Omlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Nature Medicine
|
June 1, 2024
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial
Thomas Powles, Yen-Hwa Chang, Yoshiaki Yamamoto, et al.
European Urology Oncology
|
July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update
Georgios Gakis, Harman M Bruins, Richard Cathomas, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
European Urology
|
May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
The Lancet. Oncology
|
October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Stefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
Swiss Medical Weekly
|
August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
Arnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 79) with videos related to
Sort By:
Page
of 8
European Urology Open Science
|
May 15, 2023
Patient and General Population Preferences Regarding the Benefits and Harms of Treatment for Metastatic Prostate Cancer: A Discrete Choice Experiment
Dominik Menges, Michela C Piatti, Aurelius Omlin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 14, 2023
Randomized Phase II Cabazitaxel Dose Individualization and Neutropenia Prevention Trial in Patients with Metastatic Castration-Resistant Prostate Cancer
Aurelius Omlin, Richard Cathomas, Gunhild von Amsberg, et al.
Nature Medicine
|
June 1, 2024
Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trial
Thomas Powles, Yen-Hwa Chang, Yoshiaki Yamamoto, et al.
European Urology Oncology
|
July 2, 2020
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update
Georgios Gakis, Harman M Bruins, Richard Cathomas, et al.
Swiss Medical Weekly
|
September 8, 2021
Swiss germ-cell cancer consensus recommendations
Jörg Beyer, Dominik Berthold, Peter-Karl Bode, et al.
European Urology
|
May 4, 2020
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al.
The Lancet. Oncology
|
October 13, 2022
Single-dose carboplatin followed by involved-node radiotherapy for stage IIA and stage IIB seminoma (SAKK 01/10): a single-arm, multicentre, phase 2 trial
Alexandros Papachristofilou, Jens Bedke, Stefanie Hayoz, et al.
European Urology Oncology
|
December 24, 2019
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel
Harman M Bruins, Erik Veskimäe, Virginia Hernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I Seminoma
Stefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
Swiss Medical Weekly
|
August 20, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer
Arnoud J Templeton, Aurelius Omlin, Dominik Berthold, et al.
Page
of 8